Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $23.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $23.00 | Outperform | Robert W. Baird |
| 4/22/2024 | $25.00 | Buy | Citigroup |
| 3/6/2024 | $22.00 | Equal Weight | Barclays |
| 2/26/2024 | $33.00 → $25.00 | Buy | Jefferies |
| 2/22/2024 | $21.00 | Buy → Neutral | BofA Securities |
| 12/6/2023 | $27.00 | Mkt Outperform | JMP Securities |
| 6/13/2023 | $34.00 | Outperform | Evercore ISI |
ARLINGTON, Va., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $176.6 million through the Medicare Shared Savings Program (MSSP) for the 2023 performance year, a 34.1% increase from 2022. The 10 ACOs (collectively, Privia Quality Network or PQN) managed over $2.3 billion in healthcare benchmark spend through approximately 2,850 providers delivering high-value, cost-efficient care to 194,786 Medicare beneficiaries in 2023. "The success of Privia Quality Network in MSSP is a testament to the dedication and skill of our doctors, who provided exceptional care to nearly 195,000
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
8-K - Privia Health Group, Inc. (0001759655) (Filer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
ARLINGTON, Va., July 11, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2024 before market open on Thursday, August 8, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us
ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it
Analysts' ratings for Privia Health Gr (NASDAQ:PRVA) over the last quarter vary from bullish to bearish, as provided by 7 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 1 1 0 0 3M Ago 2 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.0, along with a high estimate of $26.00 and a low estimate of $19.00. This current average represents a 16.67% de
Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $23 to $20.
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform. Privia Health Group The Trade: Privia Health Group, Inc. (NASDAQ:PRVA) Director Adam Boehler acquired a total of 4,280 sha
KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00
Robert W. Baird initiated coverage of Privia Health with a rating of Outperform and set a new price target of $23.00
Citigroup initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00